In addition, tRFs and their analogs can affect the tumor gene mRNA binding protein Y‐box binding protein 1 (YBX1), by blocking its interaction with oncogenic mRNA and destabilizing oncogene mRNAs, thereby inhibiting tumor cell infiltration.10 Here, YBX1 is linked to neoplasm.